Right to Try for Individualized Treatments Act
Bill Summary
Allows patients to access individualized treatments that are not yet approved by the Food and Drug Administration (FDA)
Sponsored By
Bill Journey
- Jun 8, 2026
- Jun 8, 2026You Are Here
The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.
- TBD
The full chamber debates the bill, may amend it, and votes on whether to pass it.
- TBD
If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.
- TBD
If passed by both chambers, the bill goes to the President to sign into law or veto.
Why It Matters
This bill affects patients with serious or life-threatening diseases, giving them the option to try experimental treatments that are not yet widely available, potentially improving their health outcomes.
Impact Areas
Support & Opposition
- Republican1
Documents
1
Full text opens on congress.gov, the official source.
Bill Details
Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.
